CLINICAL_TRIALS
trial_result
· 2016-08-31
Clinical Trial Update: Oral Bioavailability and Mass Balance Trial With Pimasertib [Phase 1]
Summary
Phase 1 trial evaluating oral bioavailability and mass balance of pimasertib in patients with locally advanced or metastatic solid tumors; results have been pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Locally Advanced or Metastatic Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2016-08-31